273 related articles for article (PubMed ID: 24947412)
41. [Assessment of hand-foot syndrome in cancer patients treated with capecitabine-containing chemotherapy].
Yamagiwa K; Shigematsu T; Takeda K; Shirai M; Amemori K; Sunda K; Koike C; Yamada T
Gan To Kagaku Ryoho; 2013 Dec; 40 Suppl 2():161-3. PubMed ID: 24712132
[TBL] [Abstract][Full Text] [Related]
42. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
43. Medullary thyroid cancer treated by capecitabine.
Labidi SI; Gravis G; Tarpin C; Brun V; Viens P
Anticancer Drugs; 2007 Aug; 18(7):831-4. PubMed ID: 17581307
[TBL] [Abstract][Full Text] [Related]
44. Acute cardiotoxicity during capecitabine treatment: a case report.
Bertolini A; Flumanò M; Fusco O; Muffatti A; Scarinci A; Pontiggia G; Scopelliti M
Tumori; 2001; 87(3):200-6. PubMed ID: 11504378
[TBL] [Abstract][Full Text] [Related]
45. Onycholysis associated with capecitabine in patients with breast cancer.
Hogeling M; Howard J; Kanigsberg N; Finkelstein H
J Cutan Med Surg; 2008; 12(2):93-5. PubMed ID: 18346407
[TBL] [Abstract][Full Text] [Related]
46. Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.
Disel U; Gürkut O; Abali H; Kaleağasi H; Mertsoylu H; Ozyilkan O; Saif MW
Cutan Ocul Toxicol; 2010 Jun; 29(2):140-2. PubMed ID: 20298142
[TBL] [Abstract][Full Text] [Related]
47. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
Dalmau J; Roé E; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
[No Abstract] [Full Text] [Related]
48. Nail and periungual toxicity following capecitabine therapy.
Vaccaro M; Barbuzza O; Guarneri F; Guarneri B
Br J Clin Pharmacol; 2008 Aug; 66(2):325-6. PubMed ID: 18384441
[No Abstract] [Full Text] [Related]
49. Is adjuvant therapy with three-dimensional conformal irradiation combined with capecitabine (Xeloda) for gastric cancer effective?
Pistevou-Gompaki K; Kouloulias V; Papaloukas C; Eleftheriadis D; Andronikidis I; Eleftheriadis N; Bitzilekis D
Dig Liver Dis; 2005 Nov; 37(11):894-5. PubMed ID: 16085471
[No Abstract] [Full Text] [Related]
50. Therapy-related acute promyelocytic leukemia after chemoradiotherapy with capecitabine for rectal adenocarcinoma.
Rashidi A; Man L; Howard JR; Atienza D; Fisher SI
Leuk Lymphoma; 2014 Mar; 55(3):683-4. PubMed ID: 23837492
[No Abstract] [Full Text] [Related]
51. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
Aprile G; Mazzer M; Moroso S; Puglisi F
Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
[TBL] [Abstract][Full Text] [Related]
52. [Severe capecitabine-associated toxicity in a patient carrying a mutation in the dihydropyrimidine dehydrogenase gen].
González-Haba E
Farm Hosp; 2012; 36(6):554-5. PubMed ID: 23461455
[No Abstract] [Full Text] [Related]
53. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
54. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
[No Abstract] [Full Text] [Related]
55. [Increased INR from concomitant use of acenocoumarol and capecitabine].
Tomlow B; Voll ML; Smorenburg CH
Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711
[TBL] [Abstract][Full Text] [Related]
56. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
Advani PP; Fakih MG
Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
[TBL] [Abstract][Full Text] [Related]
57. Atypical hand-and-foot syndrome in an African American patient treated with capecitabine with normal DPD activity: is there an ethnic disparity?
Saif MW; Sandoval A
Cutan Ocul Toxicol; 2008; 27(4):311-5. PubMed ID: 19037763
[TBL] [Abstract][Full Text] [Related]
58. [Therapy traces on hands and feet in a patient with colon cancer].
Stiefelhagen P
MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():9. PubMed ID: 22916416
[No Abstract] [Full Text] [Related]
59. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.
Arbea L; Coma-Canella I; Martinez-Monge R; García-Foncillas J
World J Gastroenterol; 2007 Apr; 13(14):2135-7. PubMed ID: 17465463
[TBL] [Abstract][Full Text] [Related]
60. Capecitabine-associated coronary vasospasm: a case report.
Papadopoulos CA; Wilson H
Emerg Med J; 2008 May; 25(5):307-9. PubMed ID: 18434478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
